Sabine Dandiguian is Managing Partner at Jeito Capital and has over 30 years of experience in Pharmaceutical and Medical Device industry with a proven track record in commercialization, new business models and management. She spent more than 20 years in growing business leadership positions at Johnson&Johnson, in particular as President of Janssen France in 2005 where she managed to transform the business model of a company founded on general medicine into a company focused on highly specialized domains (oncology, virology, psychiatry). After 5 years, she was appointed Managing Director of European emerging countries, in charge of a cluster covering Russia, Turkey, Middle East and Africa, and 3 years after was promoted Company group Chairman, President Europe in the Medical Sector of Johnson&Johnson leading a business of $3,5Md and 4500 people.
Sabine Dandiguian has been recognised as Chevalier de l’Ordre du Mérite, Chevalier de la Légion d’Honneur and is a member of the «Assemblée des 100» of Institut Pasteur.
She is member since the inception of W.I.T.H association (Women Innovating Together in Healthcare). Ms. Dandiguian received her financial degree from ESCP Business School.